Salvatore Valitutti

Salvatore Valitutti

Auto-generated profile, based on publicly available information

Salvatore Valitutti

Cancer Research Center of Toulouse, INSERM U1037, Toulouse, France

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2000 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
NHNils Holler
Nils Holler
RZRossana Zaru
Rossana Zaru
OMOlivier Micheau
Olivier Micheau
MTMargot Thome
Margot Thome
AAAntoine Attinger
Antoine Attinger
JTJürg Tschopp
Jürg Tschopp

1 May 1995 in Nature
Verified
Journal Article
Closed access
SVSalvatore Valitutti
Salvatore Valitutti
SMSabina Müller
Sabina Müller
MCMarina Cella
Marina Cella
EPElisabetta Padovan
Elisabetta Padovan
ALAntonio Lanzavecchia
Antonio Lanzavecchia

1 February 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
SVS Valitutti
S Valitutti
MDM Dessing
M Dessing
Klaus AktoriesKlaus Aktories
Klaus Aktories
HGH Gallati
H Gallati
ALA Lanzavecchia
A Lanzavecchia
Using antigen-specific T cell clones and peptide-pulsed antigen-presenting cells (APCs) we investigated the mechanisms that lead to sustained signaling, known to be required for activation of effector function. Four lines of evidence indicate that the T cell actin cytoskeleton plays a crucial role in T cell activation by antigen-pulsed APCs, but is not required when T cell receptor (TCR) is cross-linked by soluble antibodies. First, addition of antibodies to the major histocompatibility complex molecules recognized by the TCR aborts the ongoing intracellular calcium concentration ([Ca2+]i) increase in performed T-APC conjugates, indicating that the sustained signaling requires the continuous occupancy of TCR. Second, time-lapse image recording shows that T lymphocytes conjugated to peptide-pulsed APCs undergo a sustained [Ca2+]i increase, which is accompanied by the formation of a large and changing area of contact between the two opposing membranes. Third, drugs that disrupt the actin cytoskeleton, Cytochalasin D and and C2 Clostridium botulinum toxin induce a rapid block of [Ca2+]i rise, coincident with a block of the cyclic changes in T cell shape. Finally, the addition of Cytochalasin D or of anti-MHC antibodies to preformed conjugates inhibits interferon gamma production in an 1-antigen dose- and time-dependent fashion. These results identify T cell actin cytoskeleton as a major motor for sustaining signal transduction and possibly for driving TCR cross-linking and offer an explanation for how T cells equipped with low affinity TCR can be triggered by a small number of complexes on APCs.

1 November 2013 in Immunity
Verified
Journal Article
Closed access
JHJun Huang
Jun Huang
Mario BrameshuberMario Brameshuber
Mario Brameshuber
XZXun Zeng
Xun Zeng
JXJianming Xie
Jianming Xie
QLQi-Jing Li
Qi-Jing Li
MDMark M Davis
Mark M Davis

19 September 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
NGNicolas Gaudenzio
Nicolas Gaudenzio
RSRiccardo Sibilano
Riccardo Sibilano
TMThomas Marichal
Thomas Marichal
PSPhilipp Starkl
Philipp Starkl
LRLaurent L. Reber
Laurent L. Reber
SGStephen J. Galli
Stephen J. Galli
Mast cells (MCs) influence intercellular communication during inflammation by secreting cytoplasmic granules that contain diverse mediators. Here, we have demonstrated that MCs decode different activation stimuli into spatially and temporally distinct patterns of granule secretion. Certain signals, including substance P, the complement anaphylatoxins C3a and C5a, and endothelin 1, induced human MCs rapidly to secrete small and relatively spherical granule structures, a pattern consistent with the secretion of individual granules. Conversely, activating MCs with anti-IgE increased the time partition between signaling and secretion, which was associated with a period of sustained elevation of intracellular calcium and formation of larger and more heterogeneously shaped granule structures that underwent prolonged exteriorization. Pharmacological inhibition of IKK-β during IgE-dependent stimulation strongly reduced the time partition between signaling and secretion, inhibited SNAP23/STX4 complex formation, and switched the degranulation pattern into one that resembled degranulation induced by substance P. IgE-dependent and substance P–dependent activation in vivo also induced different patterns of mouse MC degranulation that were associated with distinct local and systemic pathophysiological responses. These findings show that cytoplasmic granule secretion from MCs that occurs in response to different activating stimuli can exhibit distinct dynamics and features that are associated with distinct patterns of MC-dependent inflammation.

1 April 1996 in Journal of Experimental Medicine
Verified
Journal Article
Open access
SVS Valitutti
S Valitutti
SMS Müller
S Müller
MDM Dessing
M Dessing
ALA Lanzavecchia
A Lanzavecchia
We have investigated the level of TCR occupancy required to elicit different biological responses in human CTL clones specific for an influenza matrix peptide. Specific cytotoxicity could be detected at extremely low peptide concentrations (10(-12) to 10(-15) M). However, IFN-gamma production, responsiveness to IL-2 and Ca++ fluxes were observed only at peptide concentrations > 10(-9) M, while autonomous proliferation required even higher peptide concentrations. In parallel experiments we measured TCR downregulation to estimate the number of TCRs triggered. We observed that at low peptide concentrations, where only cytotoxicity is triggered, TCR downregulation was hardly detectable. Conversely, induction of IFN-gamma production and proliferation required triggering of at least 20-50% of TCRs. Taken together these results indicate that a single CTL can graduate different biological responses as a function of antigen concentration and that killing of the specific target does not necessarily result in full activation.